FR2342292A1 - Antibiotiques, inhibiteurs de b-lactamases, clavulamiques et leur procede de preparation - Google Patents

Antibiotiques, inhibiteurs de b-lactamases, clavulamiques et leur procede de preparation

Info

Publication number
FR2342292A1
FR2342292A1 FR7705827A FR7705827A FR2342292A1 FR 2342292 A1 FR2342292 A1 FR 2342292A1 FR 7705827 A FR7705827 A FR 7705827A FR 7705827 A FR7705827 A FR 7705827A FR 2342292 A1 FR2342292 A1 FR 2342292A1
Authority
FR
France
Prior art keywords
antibiotics
beta
lactamase
useful
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7705827A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Glaxo Laboratories Ltd
Original Assignee
Laboratoires Glaxo SA
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB7897/76A external-priority patent/GB1579531A/en
Application filed by Laboratoires Glaxo SA, Glaxo Laboratories Ltd filed Critical Laboratoires Glaxo SA
Publication of FR2342292A1 publication Critical patent/FR2342292A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
FR7705827A 1976-02-27 1977-02-28 Antibiotiques, inhibiteurs de b-lactamases, clavulamiques et leur procede de preparation Withdrawn FR2342292A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB7897/76A GB1579531A (en) 1976-02-27 1976-02-27 Oxazolo-azetidinine antibiotic derivatives
GB2659476 1976-06-25
GB5261276 1976-12-16
GB5401376 1976-12-24

Publications (1)

Publication Number Publication Date
FR2342292A1 true FR2342292A1 (fr) 1977-09-23

Family

ID=27447616

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7705827A Withdrawn FR2342292A1 (fr) 1976-02-27 1977-02-28 Antibiotiques, inhibiteurs de b-lactamases, clavulamiques et leur procede de preparation

Country Status (7)

Country Link
JP (1) JPS52125191A (fr)
AU (1) AU2270977A (fr)
BE (1) BE851821A (fr)
DE (1) DE2708330A1 (fr)
DK (1) DK86277A (fr)
FR (1) FR2342292A1 (fr)
SE (1) SE7702139L (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005914A1 (fr) * 1978-05-30 1979-12-12 Beecham Group Plc Procédé chimique pour la préparation d'inhibiteurs de bêta-lactamase et les composés ainsi obtenus
WO1997010247A1 (fr) * 1995-09-15 1997-03-20 Smithkline Beecham P.L.C. Derives de l'acide clavulanique pour le traitement de l'atherosclerose

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3062168D1 (en) * 1979-04-21 1983-04-07 Beecham Group Plc Clavulanic acid derivatives, their preparation and use in pharmaceutical compositions
NZ193687A (en) * 1979-05-17 1982-12-21 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
GB2086890B (en) * 1980-10-24 1984-01-25 Beecham Group Ltd Derivatives of 2-(2'-oxo-ethylidene)-3-clavancarboxylic acid
DE3942222A1 (de) * 1989-12-21 1991-06-27 Bayer Ag Substituierte carbamoyltriazole

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005914A1 (fr) * 1978-05-30 1979-12-12 Beecham Group Plc Procédé chimique pour la préparation d'inhibiteurs de bêta-lactamase et les composés ainsi obtenus
WO1997010247A1 (fr) * 1995-09-15 1997-03-20 Smithkline Beecham P.L.C. Derives de l'acide clavulanique pour le traitement de l'atherosclerose

Also Published As

Publication number Publication date
DK86277A (da) 1977-08-28
DE2708330A1 (de) 1977-09-08
JPS52125191A (en) 1977-10-20
AU2270977A (en) 1978-08-31
SE7702139L (sv) 1977-10-10
JPS6126547B2 (fr) 1986-06-20
BE851821A (fr) 1977-08-25

Similar Documents

Publication Publication Date Title
GB2000138A (en) Therapeutic agents
SE8306328D0 (sv) Estrar av klavulansyra
ES8104300A1 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol.
FR2342292A1 (fr) Antibiotiques, inhibiteurs de b-lactamases, clavulamiques et leur procede de preparation
IE850475L (en) 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides as beta-lactamase inhibitors
ES8106528A1 (es) Un procedimiento para la preparacion de un compuesto de 1,1-dioxido de penam
NL7702027A (en) Clavulanic acid derivs. substd. by sulphur nucleophiles - useful as antibiotics and inhibitors of beta:lactamase
ES445913A1 (es) Un procedimiento para la preparacion de una sal dibasica farmaceuticamente aceptable de m. m. 17880.
ES453508A1 (es) Un procedimiento para la preparacion de nuevas sustancias antibioticas desacetil-89oa1 y desacetil-89oa2.
ES461691A1 (es) Un procedimiento para la preparacion de sales de compuestos.
ES464123A1 (es) Un procedimiento para la preparacion de esteres de acido clavulanico.
ES8103094A1 (es) Un procedimiento para la preparacion de 1,1-dioxido de acidopenicilanico y esteres del mismo
JPS56128783A (en) Beta-lactam antibacterial compound, its manufacture and its medicinal compound
ES463484A1 (es) Un procedimiento de preparacion de derivados del acido aci- lamino-clavulanico.
SE7612963L (sv) Tienamycinderivat
FR2336130A1 (fr) Composes utilisables dans le traitement des infections bacteriennes
IT1036078B (it) Composizione antibatterica per anima i
SE7712645L (sv) Monocykliska beta-laktamer med antibakteriell aktivitet
ES8300771A1 (es) Un procedimiento para la preparacion de acidos 6-(2-abril-2(1,1-dioxopenicilanoiloximetoxicarbonil)acetamido) penicilanicos.
IE40206L (en) Cephalosporin derivatives
IL87226A0 (en) (1r,5s,6s)-2-(substituted thio)-6-((r)-1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid derivatives,their production and pharmaceutical compositions containing them
HUT42492A (en) Process for producing cepheme-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents
FR2364216A1 (fr) Derives de la clavuline et leur procede de preparation
NL7800658A (en) Antibacterial clavulanic acid amine salts - form synergistic compsn. with beta:lactam antibiotics, used e.g. in treating mastitis
JPS5622787A (en) Beta-lactam compound

Legal Events

Date Code Title Description
ST Notification of lapse